These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 36122182)

  • 21. Design, synthesis and biological evaluation of coumarin-3-carboxamides as selective carbonic anhydrase IX and XII inhibitors.
    Thacker PS; Alvala M; Arifuddin M; Angeli A; Supuran CT
    Bioorg Chem; 2019 May; 86():386-392. PubMed ID: 30763885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coumarins from
    Fois B; Distinto S; Meleddu R; Deplano S; Maccioni E; Floris C; Rosa A; Nieddu M; Caboni P; Sissi C; Angeli A; Supuran CT; Cottiglia F
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):539-548. PubMed ID: 31948300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Novel Indole-3-sulfonamide-heteroaryl Hybrids as Carbonic Anhydrase Inhibitors: Design, Synthesis and
    Chinchilli KK; Singh P; Swain B; Goud NS; Sigalapalli DK; Choli A; Angeli A; Nanduri S; Yaddanapudi VM; Supuran CT; Arifuddin M
    Anticancer Agents Med Chem; 2023; 23(11):1225-1233. PubMed ID: 36847230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel 3-(6-methylpyridin-2-yl)coumarin-based chalcones as selective inhibitors of cancer-related carbonic anhydrases IX and XII endowed with anti-proliferative activity.
    Tawfik HO; Shaldam MA; Nocentini A; Salem R; Almahli H; Al-Rashood ST; Supuran CT; Eldehna WM
    J Enzyme Inhib Med Chem; 2022 Dec; 37(1):1043-1052. PubMed ID: 35437108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Coumarin-pyrazoline Hybrids as Selective Inhibitors of the Tumor-associated Carbonic Anhydrase IX and XII.
    Redij A; Carradori S; Petreni A; Supuran CT; Toraskar MP
    Anticancer Agents Med Chem; 2023; 23(10):1217-1223. PubMed ID: 36825712
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 5-Arylisothiazol-3(2H)-one-1,(1)-(di)oxides: A new class of selective tumor-associated carbonic anhydrases (hCA IX and XII) inhibitors.
    Cornelio B; Laronze-Cochard M; Miambo R; De Grandis M; Riccioni R; Borisova B; Dontchev D; Machado C; Ceruso M; Fontana A; Supuran CT; Sapi J
    Eur J Med Chem; 2019 Aug; 175():40-48. PubMed ID: 31071549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII.
    Żołnowska B; Sławiński J; Pogorzelska A; Chojnacki J; Vullo D; Supuran CT
    Eur J Med Chem; 2014 Jan; 71():135-47. PubMed ID: 24291567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel sulfonamide bearing coumarin scaffolds as selective inhibitors of tumor associated carbonic anhydrase isoforms IX and XII.
    Chandak N; Ceruso M; Supuran CT; Sharma PK
    Bioorg Med Chem; 2016 Jul; 24(13):2882-2886. PubMed ID: 27137360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent.
    Dar'in D; Kantin G; Kalinin S; Sharonova T; Bunev A; Ostapenko GI; Nocentini A; Sharoyko V; Supuran CT; Krasavin M
    Eur J Med Chem; 2021 Oct; 222():113589. PubMed ID: 34147910
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discovery of curcumin inspired sulfonamide derivatives as a new class of carbonic anhydrase isoforms I, II, IX, and XII inhibitors.
    Ramya PVS; Angapelly S; Angeli A; Digwal CS; Arifuddin M; Babu BN; Supuran CT; Kamal A
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):1274-1281. PubMed ID: 28965419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploring the potency of diazo-coumarin containing hybrid molecules: Selective inhibition of tumor-associated carbonic anhydrase isoforms IX and XII.
    Yapar G; Lolak N; Bonardi A; Akocak S; Supuran CT
    ChemMedChem; 2024 Feb; 19(4):e202300626. PubMed ID: 38193633
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological evaluation, radiosensitizing activity and structural insights of novel halogenated quinazoline-sulfonamide conjugates as selective human carbonic anhydrases IX/XII inhibitors.
    Ghorab MM; Soliman AM; Bua S; Supuran CT
    Bioorg Chem; 2021 Feb; 107():104618. PubMed ID: 33485104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition Studies on Carbonic Anhydrase Isoforms I, II, IX, and XII with a Series of Sulfaguanidines.
    Abdoli M; De Luca V; Capasso C; Supuran CT; Žalubovskis R
    ChemMedChem; 2023 Mar; 18(6):e202200658. PubMed ID: 36691902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structural investigations on coumarins leading to chromeno[4,3-c]pyrazol-4-ones and pyrano[4,3-c]pyrazol-4-ones: New scaffolds for the design of the tumor-associated carbonic anhydrase isoforms IX and XII.
    Bonardi A; Falsini M; Catarzi D; Varano F; Di Cesare Mannelli L; Tenci B; Ghelardini C; Angeli A; Supuran CT; Colotta V
    Eur J Med Chem; 2018 Feb; 146():47-59. PubMed ID: 29407972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective carbonic anhydrase IX and XII inhibitors based around a functionalized coumarin scaffold.
    Huwaimel BI; Jonnalagadda SK; Jonnalagadda S; Kumari S; Nocentini A; Supuran CT; Trippier PC
    Drug Dev Res; 2023 Jun; 84(4):681-702. PubMed ID: 36872587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continued Structural Exploration of Sulfocoumarin as Selective Inhibitor of Tumor-Associated Human Carbonic Anhydrases IX and XII.
    Giovannuzzi S; Capasso C; Nocentini A; Supuran CT
    Molecules; 2022 Jun; 27(13):. PubMed ID: 35807318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors.
    Moi D; Vittorio S; Angeli A; Balboni G; Supuran CT; Onnis V
    Molecules; 2022 Dec; 28(1):. PubMed ID: 36615285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New coumarin/sulfocoumarin linked phenylacrylamides as selective transmembrane carbonic anhydrase inhibitors: Synthesis and in-vitro biological evaluation.
    Swain B; Angeli A; Singh P; Supuran CT; Arifuddin M
    Bioorg Med Chem; 2020 Aug; 28(15):115586. PubMed ID: 32631564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity.
    Ibrahim HS; Abdelrahman MA; Nocentini A; Bua S; Abdel-Aziz HA; Supuran CT; Abou-Seri SM; Eldehna WM
    Bioorg Chem; 2022 Sep; 126():105888. PubMed ID: 35661530
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel 2-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)-1-(1,3,5-triazin-2-ylamino)guanidine derivatives: Inhibition of human carbonic anhydrase cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII, anticancer activity, and molecular modeling studies.
    Żołnowska B; Sławiński J; Szafrański K; Angeli A; Supuran CT; Kawiak A; Wieczór M; Zielińska J; Bączek T; Bartoszewska S
    Eur J Med Chem; 2018 Jan; 143():1931-1941. PubMed ID: 29146134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.